121
Participants
Start Date
March 29, 2022
Primary Completion Date
August 14, 2024
Study Completion Date
August 14, 2024
Irreversible Electroporation
IRE of the prostate is typically performed with the subject in the lithotomy position, with 2-6 monopolar probes placed through the perineum using a brachytherapy grid and ultrasound or CT guidance. IRE supplies the targeted tissue with high voltage (2-3 kV) direct current pulses lasting up to 100 microseconds through the electrode probes.
NYU Langone Health, New York
Northwell Health, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine, New York
Fox Chase Cancer Center, Philadelphia
Duke University, Durham
University of Florida Health, Gainesville
Moffitt Cancer Center, Tampa
University of Cincinnati, Cincinnati
VA Ann Arbor Health Care, Ann Arbor
Mayo Clinic, Rochester
Northshore University Healthsystem, Evanston
Duly Health and Care, Lisle
Rush University Medical Center, Chicago
University of Texas Southwestern Medical Center, Dallas
University of Colorado, Aurora
University of California Irvine, Orange
Lead Sponsor
Angiodynamics, Inc.
INDUSTRY